Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Odin

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinics in Liver Disease|November 16, 2016
Epidemiology and Genetic Risk Factors of Drug HepatotoxicityJawad Ahmad, Joseph A Odin
The Mount Sinai Journal of Medicine, New York|September 12, 2003
Primary biliary cirrhosis: a Mount Sinai perspectiveNancy Bach, Joseph A Odin
Autoimmunity Reviews|July 10, 2003
Apoptosis and the liver: relation to autoimmunity and related conditionsJingxiang Bai, Joseph A Odin
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Toll-like receptors and liver diseaseVivek Kesar, Joseph A Odin
Clinics in Liver Disease|May 6, 2008
Recent advances in the epidemiology of primary biliary cirrhosisRebekah G Gross, Joseph A Odin
Seminars in Liver Disease|August 14, 2009
Vaccination as a triggering event for autoimmune hepatitisPonni Perumalswami, Lan Peng, Joseph A Odin
Expert Review of Gastroenterology & Hepatology|September 14, 2011
Update on the epidemiology of primary biliary cirrhosisNelson Chuang, Rebekah G Gross, Joseph A Odin
Current Gastroenterology Reports|April 13, 2021
An Approach to Drug-Induced Liver Injury from the Geriatric PerspectiveBrian T Lee, Joseph A Odin, Priya Grewal
Molecular and Cellular Biochemistry|June 5, 2012
Catalase and estradiol inhibit mitochondrial protein S-glutathionylationBin Hu, Jorge Allina, Jingxiang Bai, et al.
Journal of Immunotoxicology|April 3, 2008
Pathogenic role of environmental toxins in immune-mediated liver diseasesCarmen M Stanca, Jawad Babar, Vineet Singal, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinics in Liver Disease|November 16, 2016
Epidemiology and Genetic Risk Factors of Drug HepatotoxicityJawad Ahmad, Joseph A Odin
The Mount Sinai Journal of Medicine, New York|September 12, 2003
Primary biliary cirrhosis: a Mount Sinai perspectiveNancy Bach, Joseph A Odin
Autoimmunity Reviews|July 10, 2003
Apoptosis and the liver: relation to autoimmunity and related conditionsJingxiang Bai, Joseph A Odin
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Toll-like receptors and liver diseaseVivek Kesar, Joseph A Odin
Clinics in Liver Disease|May 6, 2008
Recent advances in the epidemiology of primary biliary cirrhosisRebekah G Gross, Joseph A Odin
Seminars in Liver Disease|August 14, 2009
Vaccination as a triggering event for autoimmune hepatitisPonni Perumalswami, Lan Peng, Joseph A Odin
Expert Review of Gastroenterology & Hepatology|September 14, 2011
Update on the epidemiology of primary biliary cirrhosisNelson Chuang, Rebekah G Gross, Joseph A Odin
Current Gastroenterology Reports|April 13, 2021
An Approach to Drug-Induced Liver Injury from the Geriatric PerspectiveBrian T Lee, Joseph A Odin, Priya Grewal
Molecular and Cellular Biochemistry|June 5, 2012
Catalase and estradiol inhibit mitochondrial protein S-glutathionylationBin Hu, Jorge Allina, Jingxiang Bai, et al.
Journal of Immunotoxicology|April 3, 2008
Pathogenic role of environmental toxins in immune-mediated liver diseasesCarmen M Stanca, Jawad Babar, Vineet Singal, et al.
Pageof 5